Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Preterm infants are randomized to received either Intra-tracheal instillation of budesonide
using surfactant as vehicle or a placebo. Intra-tracheal instillation of budesonide using
surfactant as vehicle would facilitate its delivery to the periphery of the lung and would
inhibit lung inflammation and mitigate acute lung injury.